Cargando…

Association between renal function and platelet reactivity during aspirin therapy in elderly patients with atherosclerotic cardiovascular disease

BACKGROUND: Aspirin is the key treatment in the secondary prevention of atherosclerotic cardiovascular disease. High on-treatment platelet reactivity (HTPR) to aspirin has been reported to partially account for the enhanced risk of thrombotic events. In particular, HTPR has been described more frequ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Wenyi, Zhang, Peng, Liu, Meilin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821654/ https://www.ncbi.nlm.nih.gov/pubmed/33482738 http://dx.doi.org/10.1186/s12877-021-02018-y

Ejemplares similares

Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
por: Zhang, JW, et al.
Publicado: (2017)

Platelets, Aspirin and Cardiovascular Disease
por: Elwood, P. C.
Publicado: (1976)

Low dose aspirin therapy and renal function in elderly patients
por: Akinwusi, Patience Olayinka, et al.
Publicado: (2013)

Influence of Sex on Platelet Reactivity in Response to Aspirin
por: Friede, Kevin A., et al.
Publicado: (2020)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Rationale and Design of LAPIS: A Multicenter Prospective Cohort Study to Investigate the Efficacy and Safety of Low-Dose Aspirin in Elderly Chinese Patients
por: Wang, Xiting, et al.
Publicado: (2022)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases
por: Zhao, Yixi, et al.
Publicado: (2021)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

Associations Between PFA-Measured Aspirin Resistance, Platelet Count, Renal Function, and Angiotensin Receptor Blockers
por: Chen, Hung Yi, et al.
Publicado: (2018)

Genetic Determinants of On-Aspirin Platelet Reactivity: Focus on the Influence of PEAR1
por: Würtz, Morten, et al.
Publicado: (2014)

Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
por: Crescente, Marilena, et al.
Publicado: (2018)

Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Puccini, Marianna, et al.
Publicado: (2022)

Increased Platelet Reactivity Is Associated with Circulating Platelet-Monocyte Complexes and Macrophages in Human Atherosclerotic Plaques
por: Rutten, Bert, et al.
Publicado: (2014)

High-on-Aspirin Platelet Reactivity Differs Between Recurrent Ischemic Stroke Associated With Extracranial and Intracranial Atherosclerosis
por: Noh, Kyung Chul, et al.
Publicado: (2022)

Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor
por: Costa, Thiago Guarato Rodrigues, et al.
Publicado: (2022)

Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention
por: Nardin, Matteo, et al.
Publicado: (2023)

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry
por: Mayer, Katharina, et al.
Publicado: (2023)

Recovery Time of Platelet Function After Aspirin Withdrawal
por: Lee, Jeonghun, et al.
Publicado: (2014)

The Effects of Cyclosporine and Aspirin on Platelet Function in Normal Dogs
por: Thomason, J., et al.
Publicado: (2016)

Fifty years with aspirin and platelets
por: Patrono, Carlo
Publicado: (2022)

Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats
por: Soni, Hitesh M., et al.
Publicado: (2014)

Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach
por: Cofer, Lucas B., et al.
Publicado: (2022)

Serum ω-3 Polyunsaturated Fatty Acids and Potential Influence Factors in Elderly Patients with Multiple Cardiovascular Risk Factors
por: Liu, Wenwen, et al.
Publicado: (2018)

High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome
por: Liu, Lin, et al.
Publicado: (2016)

High Residual Platelet Reactivity during Aspirin Therapy in Patients with Non-St Segment Elevation Acute Coronary Syndrome: Comparison Between Initial and Late Phases
por: Dracoulakis, Marianna Deway Andrade, et al.
Publicado: (2019)

Androgen therapy and atherosclerotic cardiovascular disease
por: McGrath, K-CY, et al.
Publicado: (2008)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Use of Aspirin for Prevention of Recurrent Atherosclerotic Cardiovascular Disease Among Adults — 20 States and the District of Columbia, 2013
por: Fang, Jing, et al.
Publicado: (2015)

Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity
por: Oggero, Silvia, et al.
Publicado: (2021)

Activation of activator protein 2 alpha by aspirin alleviates atherosclerotic plaque growth and instability in vivo
por: Yang, Jing-Jing, et al.
Publicado: (2016)

Is there a benefit of aspirin therapy for primary prevention to reduce the risk of atherosclerotic cardiovascular disease in patients with elevated Lipoprotein (a)—A review of the evidence
por: Sukkari, Mohamad Hekmat, et al.
Publicado: (2023)

Novel Aspects Targeting Platelets in Atherosclerotic Cardiovascular Disease—A Translational Perspective
por: Huseynov, Aydin, et al.
Publicado: (2023)

Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives
por: Melnikov, Ivan, et al.
Publicado: (2023)

Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study
por: Jurk, Kerstin, et al.
Publicado: (2022)

Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
por: Yang, Tae-Hyun, et al.
Publicado: (2009)

Associated factors and hemodynamic characteristics of resistant hypertension in the elderly
por: Geng, Hui, et al.
Publicado: (2023)

SARS-COV-2 PLATELET FUNCTION & THROMBOTIC COMPLICATIONS: EFFECTS OF ASPIRIN THERAPY IN COVID-19
por: Bhandari, Rohan, et al.
Publicado: (2021)

Safety of Low-Dose Aspirin in Endovascular Treatment for Intracranial Atherosclerotic Stenosis
por: Ma, Ning, et al.
Publicado: (2014)

Endovascular Management of Atherosclerotic Renal Artery Stenosis: Post-Cardiovascular Outcomes in Renal Atherosclerotic Lesions Era Winner or False Alarm?
por: Karanikola, Evridiki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_urohkmqckka5edmpuj2lerpgea